---
title: "Arch Therapeutics, Inc. (ARTH.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ARTH.US.md"
symbol: "ARTH.US"
name: "Arch Therapeutics, Inc."
industry: "醫療用品"
---

# Arch Therapeutics, Inc. (ARTH.US)

| Item | Detail |
|------|--------|
| Industry | 醫療用品 |

## Company Profile

ARCH 治療公司是一家發展階段的生物技術公司，致力于止血和密封技術平台的開發和提供。它的候選產品包括 AC5 設備，該設備旨在實現手術、傷口和介入護理期間的止血。該公司由 Rutledge Ellis-Behnke 和 Terence W.NORCHI 于2009年9月16日創立，總部設在馬薩諸塞州弗雷明翰。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:12.000Z

**Overall: C (0.56)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 33 / 43 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 292.25% |  |
| Net Profit YoY | -102.56% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 148163.00 |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 126.29% | A |
| Profit Margin | -8276.47% | E |
| Gross Margin | 31.81% | C |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 292.25% | A |
| Net Profit YoY | -102.56% | E |
| Total Assets YoY | -10.65% | E |
| Net Assets YoY | -56.71% | E |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1.14% | D |
| OCF YoY | 292.25% | A |

#### Operating Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.10 | E |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 998.70% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Arch Therapeutics, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "126.29%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-8276.47%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "31.81%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "292.25%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-102.56%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-10.65%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-56.71%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1.14%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "292.25%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "E",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.10",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "998.70%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 依視路(ADR) (US.ESLOY) | B | B | C | B | B | B |
| 02 | HOYA Corporation (US.HOCPY) | A | B | B | A | C | B |
| 03 | 愛齊科技 (US.ALGN) | B | C | B | B | C | B |
| 04 | Merit醫療系統 (US.MMSI) | B | B | B | C | B | B |
| 05 | UFP 科技 (US.UFPT) | B | B | A | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.07 | 14/44 | - | - | - |
| PB | -0.07 | 37/44 | - | - | - |
| PS (TTM) | 6.00 | 33/44 | 6.00 | 6.00 | 6.00 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/ARTH.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ARTH.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ARTH.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.